Experimental CAR t therapy takes on Hard-to-Treat solid tumors
NCT ID NCT06193902
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 30 times
Summary
This early-stage trial tests a new treatment called LEU011 for people with solid tumors that have come back or not responded to standard therapies. LEU011 uses a patient's own immune cells, modified to target specific markers on tumor cells. The main goals are to check safety and find the best dose, with 17 participants expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR, SOLID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guy's and St Thomas' NHS Foundation Trust
RECRUITINGLondon, SE1 9RT, United Kingdom
Contact
Contact Phone: •••-•••-••••
-
The Christie NHS Foundation Trust
RECRUITINGManchester, M20 4BX, United Kingdom
Contact
Contact
Conditions
Explore the condition pages connected to this study.